A few years ago, Versus Arthritis funded the inclusion of a chronic pain questionnaire in the Health Survey for England. The findings from these questions are stark. Of great concern is that 5.5 million people in England (12% of the population) have high-impact chronic pain, the most severe form, which means a person struggles to take part in daily activities such as self-care, family, community and work.
Versus Arthritis’ new report, ‘Chronic pain in England: Unseen, unequal, unfair’ sets out key findings from the survey (initially analysed by Public Health England) 
and a series of recommendations which call for a fundamental re-think in how we support people with chronic pain through far-reaching solutions.…
Read more of this article
CEO update by Sue Brown
The University of Manchester is looking for people with arthritis or any other long-term musculoskeletal pain condition to take part in the Manchester Digital Pain Manikin study.
The 
NOA webinar: Integrated Care Systems (ICS): the new world of musculoskeletal care (part 2)
Grünenthal is a research-driven pharmaceutical company specialising in the provision of treatments for managing pain. We are a leading global provider of innovative treatments and state-of-the-art technologies for people living with pain in the UK and around the world.
Physio First is one of the professional networks of the Chartered Society of Physiotherapy and represents private practitioners. They have been successful in gaining some funding from CSP to help them and other professional networks to identify barriers and challenges to producing their own individual Equality, Diversity and Inclusion (EDI) policies. This successful funding bid has been achieved in conjunction with another of the CSP’s networks, who focus on diversity, the LGBTQIA+ network.… 
The Royal Osteoporosis Society (ROS) has launched its 2021 